KR20160064410A - 스피큘을 포함하는 피부관리용 화장품 조성물 및 이의 제조방법 - Google Patents
스피큘을 포함하는 피부관리용 화장품 조성물 및 이의 제조방법 Download PDFInfo
- Publication number
- KR20160064410A KR20160064410A KR1020140167990A KR20140167990A KR20160064410A KR 20160064410 A KR20160064410 A KR 20160064410A KR 1020140167990 A KR1020140167990 A KR 1020140167990A KR 20140167990 A KR20140167990 A KR 20140167990A KR 20160064410 A KR20160064410 A KR 20160064410A
- Authority
- KR
- South Korea
- Prior art keywords
- growth factor
- skin
- composition
- weight
- agent
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 239000002537 cosmetic Substances 0.000 claims abstract description 27
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims abstract description 19
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims abstract description 18
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims abstract description 18
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims abstract description 18
- 238000000855 fermentation Methods 0.000 claims abstract description 14
- 230000004151 fermentation Effects 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 14
- 239000000419 plant extract Substances 0.000 claims abstract description 10
- QMIFIFIYYPUVNU-ACMTZBLWSA-L copper (2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-imidazol-1-id-4-ylpropanoyl]amino]hexanoate Chemical compound [Cu+2].NCCCC[C@@H](C([O-])=O)NC(=O)[C@@H](NC(=O)CN)CC1=C[N-]C=N1 QMIFIFIYYPUVNU-ACMTZBLWSA-L 0.000 claims abstract description 9
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims abstract description 8
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims abstract description 8
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 239000000654 additive Substances 0.000 claims abstract description 4
- 230000000996 additive effect Effects 0.000 claims abstract description 4
- 239000003102 growth factor Substances 0.000 claims description 21
- 210000000130 stem cell Anatomy 0.000 claims description 21
- 230000037303 wrinkles Effects 0.000 claims description 19
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 17
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 17
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 17
- 230000000694 effects Effects 0.000 claims description 15
- 230000010261 cell growth Effects 0.000 claims description 14
- 241000208340 Araliaceae Species 0.000 claims description 10
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 10
- 235000008434 ginseng Nutrition 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 238000004113 cell culture Methods 0.000 claims description 6
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 claims description 6
- 244000294611 Punica granatum Species 0.000 claims description 5
- 235000014360 Punica granatum Nutrition 0.000 claims description 5
- 230000037394 skin elasticity Effects 0.000 claims description 5
- 239000003009 skin protective agent Substances 0.000 claims description 5
- 230000037319 collagen production Effects 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 230000003020 moisturizing effect Effects 0.000 claims description 4
- 239000004034 viscosity adjusting agent Substances 0.000 claims description 4
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 3
- 241000194017 Streptococcus Species 0.000 claims description 3
- 235000021536 Sugar beet Nutrition 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 3
- 239000012930 cell culture fluid Substances 0.000 claims description 2
- 230000008472 epithelial growth Effects 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims description 2
- 102000014429 Insulin-like growth factor Human genes 0.000 claims 5
- 241000238557 Decapoda Species 0.000 claims 1
- 239000004909 Moisturizer Substances 0.000 claims 1
- 210000004504 adult stem cell Anatomy 0.000 claims 1
- 238000004299 exfoliation Methods 0.000 claims 1
- 230000001333 moisturizer Effects 0.000 claims 1
- 102000013275 Somatomedins Human genes 0.000 abstract description 14
- 210000003491 skin Anatomy 0.000 description 56
- 210000004027 cell Anatomy 0.000 description 21
- 239000000243 solution Substances 0.000 description 12
- 241000243142 Porifera Species 0.000 description 11
- 230000036560 skin regeneration Effects 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- 230000032683 aging Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000007423 decrease Effects 0.000 description 5
- 230000002500 effect on skin Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 230000008929 regeneration Effects 0.000 description 5
- 238000011069 regeneration method Methods 0.000 description 5
- 231100000241 scar Toxicity 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 210000002919 epithelial cell Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- -1 5-aminolevulinic acid ester Chemical class 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- 108010057266 Type A Botulinum Toxins Proteins 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 229940089093 botox Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 238000011321 prophylaxis Methods 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- HFWHTGSLDKKCMD-UHFFFAOYSA-N 2,2-bis(octanoyloxymethyl)butyl octanoate Chemical compound CCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCC)COC(=O)CCCCCCC HFWHTGSLDKKCMD-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001400472 Omiza Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 208000022760 infectious otitis media Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- VYZKQGGPNIFCLD-UHFFFAOYSA-N 3,3-dimethylhexane-2,2-diol Chemical compound CCCC(C)(C)C(C)(O)O VYZKQGGPNIFCLD-UHFFFAOYSA-N 0.000 description 1
- PBFGMXZRJIUGKU-UHFFFAOYSA-N 3-decanoyloxybutyl decanoate Chemical compound CCCCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCCCC PBFGMXZRJIUGKU-UHFFFAOYSA-N 0.000 description 1
- LFESLSYSZQYEIZ-UHFFFAOYSA-N 3-octanoyloxybutyl octanoate Chemical compound CCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCC LFESLSYSZQYEIZ-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- 235000018865 Angelica gigas Nutrition 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 description 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000002265 Human Growth Hormone Human genes 0.000 description 1
- 108010000521 Human Growth Hormone Proteins 0.000 description 1
- 239000000854 Human Growth Hormone Substances 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000024777 Prion disease Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- GVFLRRUWVHAQRF-UHFFFAOYSA-N [Na].OCC(O)CO.C(CCCO)O Chemical compound [Na].OCC(O)CO.C(CCCO)O GVFLRRUWVHAQRF-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229960002749 aminolevulinic acid Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000012754 barrier agent Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 229940114374 butylene glycol dicaprylate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 230000031776 germ cell proliferation Effects 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-N hexanedioic acid Natural products OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000059 polyethylene glycol stearate Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229930193195 schizandrin Natural products 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 229950003429 sorbitan palmitate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
도 2는 조성물의 사용 전(A) 보다 후(B)에 피부톤이 밝아지고 잔주름이 개선되었으며, 깊은 주름이 엷여진 것을 나타낸다.
Claims (9)
- 스피큘을 준비하는 단계;
인체지방줄기세포 배양액(AAPE)과 세포성장인자(Cell Growth Factor: CGF)인 상피세포성장인자(EGF), 혈관내피성장인자(VEGF), 섬유아세포 성장인자(FGF), 인슐린유사 성장인자(IGF-1) 및 아세틸헥사펩타이드-8, 카퍼트리펩타이드-1(Copper tripeptide-1), 인삼캘러스 배양액, 식물추출물 발효액을 혼합하여 조성물을 준비하는 단계;
상기 스피큘을 상기 혼합된 조성물에 24 내지 48시간 침지하는 단계;
상기 침지된 스피큘에 보습제, 피부보호제, 점도조절제, 유화제가 혼합된 첨가제 혼합물과 섞어 화장품 조성물을 제조하는 단계;를 포함하는 피부관리용 화장품 조성물 제조방법
- 제 1항에 있어서,
상기 첨가제 혼합물은 70 내지 80℃에서 제조하는 것을 특징으로 하는 방법
- 스피큘, 인체지방줄기세포 배양액과 세포성장인자(Cell Growth Factor: CGF)인 상피세포성장인자(EGF), 혈관내피성장인자(VEGF), 섬유아세포 성장인자(FGF), 인슐린유사 성장인자(IGF-1) 및 아세틸헥사펩타이드-8, 카퍼트리펩타이드-1(Copper tripeptide-1), 인삼캘러스 배양액, 식물추출물 발효액을 포함하는 피부관리용 화장품 조성물
- 제 3항에 있어서,
상기 식품추출물 발효액은 갈근, 승마, 석류, 오미자, 당규를 스트렙토코쿠스 터모필루스(Streptococcus thermophillus)로 발효한 것을 특징으로 하는 조성물
- 제 3항에 있어서,
상기 스피큘은 10 내지 20 중량부, 인체지방줄기세포 배양액은 20 내지 30 중량부를 포함하는 것을 특징으로 하는 조성물
- 제 3항에 있어서,
상기 세포성장인자(Cell Growth Factor: CGF)는 상피세포성장인자(EGF), 혈관내피성장인자(VEGF), 섬유아세포 성장인자(FGF), 인슐린유사 성장인자(IGF-1)를 포함하고, 아세틸헥사펩타이드-8, 카퍼트리펩타이드-1(Copper tripeptide-1), 인삼캘러스 배양액 및 식물추출물 발효액이 각각 동일한 중량부로 혼합되어 혼합물을 이루고, 상기 혼합물의 10 내지 30 중량부를 포함하는 것을 특징으로 하는 조성물
- 제 3항에 있어서,
산도조절제, 보습제, 피부보호제, 유화제, 점도 조절제를 더 포함하는 것을 특징으로 하는 조성물 - 제 3항에 있어서,
라벤더오일을 더 포함하는 것을 특징으로 하는 조성물 - 제 3항에 있어서,
상기 조성물은 콜라겐 생성을 유도하여 피부 탄력증가, 주름개선, 각질제거 효과가 있는 것을 특징으로 하는 조성물
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140167990A KR101678621B1 (ko) | 2014-11-28 | 2014-11-28 | 스피큘을 포함하는 피부관리용 화장품 조성물 및 이의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140167990A KR101678621B1 (ko) | 2014-11-28 | 2014-11-28 | 스피큘을 포함하는 피부관리용 화장품 조성물 및 이의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20160064410A true KR20160064410A (ko) | 2016-06-08 |
KR101678621B1 KR101678621B1 (ko) | 2016-11-22 |
Family
ID=56193420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140167990A KR101678621B1 (ko) | 2014-11-28 | 2014-11-28 | 스피큘을 포함하는 피부관리용 화장품 조성물 및 이의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101678621B1 (ko) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101851742B1 (ko) * | 2017-01-16 | 2018-04-24 | 주식회사 뷰렌코리아 | 사황산으로 코팅된 해면 골편을 함유하는 화장료 조성물 및 그의 제조방법 |
KR20180069488A (ko) * | 2016-12-15 | 2018-06-25 | 주식회사 제닉 | 스피큘을 포함하는 용해성 필름 및 이의 용도 |
KR20180069487A (ko) * | 2016-12-15 | 2018-06-25 | 주식회사 제닉 | 스피큘을 포함하는 하이드로겔 조성물 및 이의 용도 |
CN109125236A (zh) * | 2018-08-30 | 2019-01-04 | 谭建新 | 一种石榴酵素面膜及其制备方法和装置 |
WO2020004745A1 (ko) * | 2018-06-29 | 2020-01-02 | 주식회사 에스알바이오텍 | 약물이 코팅된 마이크로 니들 및 이의 제조방법 |
KR102203167B1 (ko) * | 2020-05-22 | 2021-01-14 | 주식회사 바이오뷰텍 | 라멜라 액정상에 봉입된 하이드롤라이즈드 해면파우더 또는 해면파우더를 함유하여 빠른 피부 재생능과 피부 및 두피 개선능이 있는 화장료 조성물 |
KR102209847B1 (ko) | 2020-11-06 | 2021-03-24 | 주식회사 본에스티스 | 피부 보습 및 진정용 기능성 화장료 조성물 |
KR102244147B1 (ko) * | 2021-01-21 | 2021-04-23 | (주)올스프링랜드 | 스피큘 추출물을 포함하는 피부, 근육의 피로 해소, 예방의 기능성 화장품 조성물 및 제조방법 |
CN112770711A (zh) * | 2019-09-06 | 2021-05-07 | 株式会社靓安9 | 用于促进经皮吸收的结构、其制造方法和包含其的化妆品组合物 |
KR102248733B1 (ko) | 2020-11-06 | 2021-05-07 | 주식회사 본에스티스 | 피부 주름 및 탄력 개선용 기능성 화장료 조성물 |
KR102333146B1 (ko) | 2021-06-14 | 2021-12-01 | 한도숙 | 스피큘을 포함하는 피부 명도 개선을 위한 화장품 조성물 및 이의 제조 방법 |
KR102333145B1 (ko) | 2021-06-14 | 2021-12-01 | 한도숙 | 스피큘을 포함하는 피부 보습도 개선을 위한 화장품 조성물 및 이의 제조 방법 |
KR102404932B1 (ko) * | 2022-02-24 | 2022-06-07 | (주)비엔 | 피부개선에 유효한 성분과 다이아몬드가 코팅된 스피큘 제조방법 및 이를 포함하는 다이아몬드 스피큘 화장료 조성물 |
CN115486537A (zh) * | 2021-06-18 | 2022-12-20 | 忠北大学校产学协力团 | 包含永生化干细胞的富含外泌体的培养液及肉毒杆菌毒素的功能性组合物 |
CN115518145A (zh) * | 2022-07-26 | 2022-12-27 | 四川大学华西医院 | 一种用于修复皮肤缺损、祛痘和/或除皱的药物 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102272303B1 (ko) * | 2018-12-13 | 2021-07-05 | (주)파이온텍 | 스피큘 세공 내 리포좀의 함침 방법 |
KR102611907B1 (ko) | 2021-03-29 | 2023-12-11 | 가치플러스 주식회사 | 스피큘 추출물을 함유한 기능성 화장품 조성물 및 이의 제조 방법 |
KR20240140405A (ko) | 2023-03-16 | 2024-09-24 | 동아대학교 산학협력단 | 줄기세포 골분화 촉진을 위한 조성물 및 이의 제조방법 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100937389B1 (ko) * | 2009-01-23 | 2010-01-19 | (주)스킨메디언스 | 해면 골편을 이용한 피부 관리 화장품 조성물의 제조방법 |
KR20110062159A (ko) * | 2009-12-02 | 2011-06-10 | (주)더페이스샵 | 장뇌삼 캘러스 추출물을 함유하는 피부 미백용 화장료 조성물 |
KR20120099550A (ko) * | 2011-01-28 | 2012-09-11 | (주)와이즈덤레버러토리 | 줄기세포 증식 촉진 기능을 갖는 피부 미백용 펩타이드 조성물 |
KR20130028548A (ko) * | 2011-09-09 | 2013-03-19 | 박수미 | 피부재생, 항염 및 피부진정용 화장료 조성물 및 그 제조방법 |
-
2014
- 2014-11-28 KR KR1020140167990A patent/KR101678621B1/ko active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100937389B1 (ko) * | 2009-01-23 | 2010-01-19 | (주)스킨메디언스 | 해면 골편을 이용한 피부 관리 화장품 조성물의 제조방법 |
KR20110062159A (ko) * | 2009-12-02 | 2011-06-10 | (주)더페이스샵 | 장뇌삼 캘러스 추출물을 함유하는 피부 미백용 화장료 조성물 |
KR20120099550A (ko) * | 2011-01-28 | 2012-09-11 | (주)와이즈덤레버러토리 | 줄기세포 증식 촉진 기능을 갖는 피부 미백용 펩타이드 조성물 |
KR20130028548A (ko) * | 2011-09-09 | 2013-03-19 | 박수미 | 피부재생, 항염 및 피부진정용 화장료 조성물 및 그 제조방법 |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180069488A (ko) * | 2016-12-15 | 2018-06-25 | 주식회사 제닉 | 스피큘을 포함하는 용해성 필름 및 이의 용도 |
KR20180069487A (ko) * | 2016-12-15 | 2018-06-25 | 주식회사 제닉 | 스피큘을 포함하는 하이드로겔 조성물 및 이의 용도 |
KR101851742B1 (ko) * | 2017-01-16 | 2018-04-24 | 주식회사 뷰렌코리아 | 사황산으로 코팅된 해면 골편을 함유하는 화장료 조성물 및 그의 제조방법 |
CN112351770B (zh) * | 2018-06-29 | 2024-06-11 | 韩国皮肤再生生物技术公司 | 涂敷药物的微针及其制造方法 |
WO2020004745A1 (ko) * | 2018-06-29 | 2020-01-02 | 주식회사 에스알바이오텍 | 약물이 코팅된 마이크로 니들 및 이의 제조방법 |
CN112351770A (zh) * | 2018-06-29 | 2021-02-09 | 韩国皮肤再生生物技术公司 | 涂敷药物的微针及其制造方法 |
JP2021528497A (ja) * | 2018-06-29 | 2021-10-21 | エスアール バイオテック インコーポレーテッドSr Biotek Inc. | 薬物がコーティングされたマイクロニードル及びその製造方法 |
CN109125236A (zh) * | 2018-08-30 | 2019-01-04 | 谭建新 | 一种石榴酵素面膜及其制备方法和装置 |
CN112770711A (zh) * | 2019-09-06 | 2021-05-07 | 株式会社靓安9 | 用于促进经皮吸收的结构、其制造方法和包含其的化妆品组合物 |
KR102203167B1 (ko) * | 2020-05-22 | 2021-01-14 | 주식회사 바이오뷰텍 | 라멜라 액정상에 봉입된 하이드롤라이즈드 해면파우더 또는 해면파우더를 함유하여 빠른 피부 재생능과 피부 및 두피 개선능이 있는 화장료 조성물 |
KR102209847B1 (ko) | 2020-11-06 | 2021-03-24 | 주식회사 본에스티스 | 피부 보습 및 진정용 기능성 화장료 조성물 |
KR102248733B1 (ko) | 2020-11-06 | 2021-05-07 | 주식회사 본에스티스 | 피부 주름 및 탄력 개선용 기능성 화장료 조성물 |
KR102244147B1 (ko) * | 2021-01-21 | 2021-04-23 | (주)올스프링랜드 | 스피큘 추출물을 포함하는 피부, 근육의 피로 해소, 예방의 기능성 화장품 조성물 및 제조방법 |
KR102333145B1 (ko) | 2021-06-14 | 2021-12-01 | 한도숙 | 스피큘을 포함하는 피부 보습도 개선을 위한 화장품 조성물 및 이의 제조 방법 |
KR102333146B1 (ko) | 2021-06-14 | 2021-12-01 | 한도숙 | 스피큘을 포함하는 피부 명도 개선을 위한 화장품 조성물 및 이의 제조 방법 |
CN115486537A (zh) * | 2021-06-18 | 2022-12-20 | 忠北大学校产学协力团 | 包含永生化干细胞的富含外泌体的培养液及肉毒杆菌毒素的功能性组合物 |
KR102404932B1 (ko) * | 2022-02-24 | 2022-06-07 | (주)비엔 | 피부개선에 유효한 성분과 다이아몬드가 코팅된 스피큘 제조방법 및 이를 포함하는 다이아몬드 스피큘 화장료 조성물 |
WO2023163298A1 (ko) * | 2022-02-24 | 2023-08-31 | (주)비엔 | 피부개선에 유효한 성분과 다이아몬드가 코팅된 스피큘 제조방법 및 이를 포함하는 다이아몬드 스피큘 화장료 조성물 |
CN115518145A (zh) * | 2022-07-26 | 2022-12-27 | 四川大学华西医院 | 一种用于修复皮肤缺损、祛痘和/或除皱的药物 |
Also Published As
Publication number | Publication date |
---|---|
KR101678621B1 (ko) | 2016-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101678621B1 (ko) | 스피큘을 포함하는 피부관리용 화장품 조성물 및 이의 제조방법 | |
KR100937389B1 (ko) | 해면 골편을 이용한 피부 관리 화장품 조성물의 제조방법 | |
EP2656832B1 (en) | Compositions for use in wound healing | |
CN101214200B (zh) | 皮肤外用液态和固态六胜肽复合纳米乳及其制备方法 | |
CN104644523B (zh) | 一种医用生物除皱抑斑敷料及其制备方法 | |
CN104856892A (zh) | 一种富含生长因子的化妆品或护肤品制剂及其制备方法 | |
CN1985791B (zh) | 护肤丝素凝胶霜膏的制备方法 | |
CN101791283B (zh) | 一种可消除妊娠纹和疤痕的化妆品 | |
CN105193673B (zh) | 一种清痘修复液及其制备方法 | |
KR20180134468A (ko) | 스피큘과 해양콜라겐 및 해양심층수를 포함하는 해양 화장품 조성물 및 이의 제조방법 | |
KR101810231B1 (ko) | 프로폴리스 미세침 분말을 함유하는 화장료 조성물 | |
KR102613845B1 (ko) | 천연물 유래의 피부개선용 화장조성물 | |
KR101895037B1 (ko) | 스피큘을 포함하는 하이드로겔 조성물 및 이의 용도 | |
US20180318356A1 (en) | Dermatological and cosmetic treatments using mesenchymal stem cells | |
Wang et al. | Platelet-rich plasma, collagen peptides, and stem cells for cutaneous rejuvenation | |
CN108175740B (zh) | 一种具有有效预防及祛除妊娠纹功效的修复霜及其制备方法 | |
RU2383341C2 (ru) | Способ омоложения кожи | |
KR20100096447A (ko) | 돼지 태반 조직 유래 줄기세포의 배양물 및 그 추출 단백질을 함유한 화장료용 조성물 | |
EP3148556A1 (en) | Skin treatment formulations | |
US20140348873A1 (en) | Urea-Silicone Gel for Hyperkeratosis Treatment | |
KR101917026B1 (ko) | 피부 주름 개선 또는 예방용 화장료 조성물 | |
CN113473963A (zh) | 化妆品/皮肤病学组合物 | |
KR20120140450A (ko) | 인간 중간엽줄기세포의 분화 촉진용 조성물 | |
CN114522232A (zh) | 促进皮肤伤口愈合配方、乳液 | |
CN103705394A (zh) | 祛痘消痕生物蚕丝面膜 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20141128 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20160321 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20161027 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20161116 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20161116 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20191008 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20191008 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20201006 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20211116 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20221116 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20231116 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20241118 Start annual number: 9 End annual number: 9 |